Number of the records: 1  

Targeting adenovirus gene delivery to activated tumour-associated vasculature via endothelial selectins

  1. 1.
    SYSNO ASEP0358495
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleTargeting adenovirus gene delivery to activated tumour-associated vasculature via endothelial selectins
    Author(s) Bachtarzi, H. (GB)
    Stevenson, M. (GB)
    Šubr, Vladimír (UMCH-V) RID, ORCID
    Ulbrich, Karel (UMCH-V) RID
    Seymour, L. W. (GB)
    Fisher, K. D. (GB)
    Source TitleJournal of Controlled Release. - : Elsevier - ISSN 0168-3659
    Roč. 150, č. 2 (2011), s. 196-203
    Number of pages8 s.
    Languageeng - English
    CountryNL - Netherlands
    KeywordsE-selectin ; pHPMA ; adenovirus
    Subject RIVEI - Biotechnology ; Bionics
    R&D Projects1M0505 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    CEZAV0Z40500505 - UMCH-V (2005-2011)
    UT WOS000289701200010
    DOI10.1016/j.jconrel.2010.10.011
    AnnotationAdenovirus (Adluc) was coated with a reactive polymer based on poly[N-(2-hydroxypropyl)methacrylamide] to ablate normal infection pathways. Linkage of a monoclonal antibody against E-selectin demonstrated E-selectin-specific transduction of tumour necrosis factor-α (TNF-α)-activated endothelial cells. A two-component targeting system using protein G was developed. We report an enhancement in transduction of TNF-α-activated endothelium in vitro and ex vivo in a human umbilical vein cord model using the E-selectin antibody. Virus retargeted using a chimeric P-selectin Glycoprotein Ligand-1-Fc fusion (PSGL-1) protein showed better circulation kinetics and uptake into HepG2 xenografts following systemic administration in mice, with 36-fold higher genome copies, compared with non-modified virus. Immunohistochemistry of tumour sections from mice treated with PSGL-1-retargeted virus showed a co-localisation of luciferase with CD31 suggesting selective endothelial targeting.
    WorkplaceInstitute of Macromolecular Chemistry
    ContactEva Čechová, cechova@imc.cas.cz ; Tel.: 296 809 358
    Year of Publishing2012
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.